Industrial bioscience company Amyris has appointed Kathleen Valiasek, a senior finance and business executive with over 20 years’ experience serving start-up, venture-backed and Fortune 500 companies as chief financial officer. She replaces Raffi Asadorian, who has resigned to pursue a new opportunity, but will continue to support specific projects, as well as serve in an ad hoc consulting capacity to ensure a smooth transition. Ms. Valiasek’s experience encompasses serving with fast-growing ...